Clario · 3 months ago
Strategic Pricing Analyst
Clario is on a mission to transform lives by unlocking better evidence. As a Strategic Pricing Analyst, you will analyze business performance, support strategic planning, and deliver actionable reporting to empower leadership across the organization.
BiotechnologyHealth CarePharmaceuticalProduct Research
Responsibilities
Analyze financial performance across funnel, bookings, backlog, revenue, expenses, cash flow, and balance sheet
Build and maintain Excel models to interpret data and deliver concise, logical conclusions
Prepare components of monthly and quarterly financial results packages and presentations
Support annual budgeting and periodic forecasting, including model development
Navigate and utilize ERP (AX), CRM (Salesforce), and other internal tools
Apply financial analysis techniques to influence business outcomes
Conduct ad-hoc performance analyses and prepare recurring financial reports
Qualification
Required
Bachelor's degree in accounting, Finance, Business, Economics, or Engineering; MBA/M.S. preferred
3+ years of experience in pricing, finance, or analytical roles
Advanced Excel and PowerPoint skills; strong modeling and profitability analysis capabilities
Experience with complex pricing structures, including volume discounts and price lists
Ability to interpret data, solve problems, and support both structured and unstructured initiatives
Skilled in presenting insights and securing stakeholder alignment
Comfortable working in cross-functional, geographically diverse teams
Highly organized, detail-oriented, and adaptable to shifting priorities
Strong judgment and decision-making in business contexts
Location: US-based, Eastern or Central Time Zone
Benefits
Competitive compensation
Medical, dental, and vision insurance beginning Day 1 of employment
Flexible work schedules
Attractive PTO plan
Engaging employee programs
Remote working
Company
Clario
Clario provides data and technology solutions for clinical trials that collect and analyze data for drug and medical device approvals.
Funding
Current Stage
Late StageTotal Funding
unknown2025-10-29Acquired
2019-10-21Private Equity
2016-05-01Series Unknown
Leadership Team
Recent News
Crunchbase News
2025-12-31
EIN Presswire
2025-11-15
Company data provided by crunchbase